Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.

Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.

Item
http://www.wikidata.org/entity/Q41358442
ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.Interaction of molecular alterations with immune response in melanoma.Predictors of responses to immune checkpoint blockade in advanced melanomaImproving radiotherapy in cancer treatment: Promises and challenges.Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.Emerging biomarkers for cancer immunotherapy in melanoma.Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.Melanoma Immunotherapy: Next-Generation Biomarkers.Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in CancerMolecular Diagnostics in Clinical Oncology
P2860

Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.

Item
http://www.wikidata.org/entity/Q41358442
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Recurrent SERPINB3 and SERPINB ...... d to anti-CTLA4 immunotherapy.
@en
type
label
Recurrent SERPINB3 and SERPINB ...... d to anti-CTLA4 immunotherapy.
@en
prefLabel
Recurrent SERPINB3 and SERPINB ...... d to anti-CTLA4 immunotherapy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
Recurrent SERPINB3 and SERPINB ...... d to anti-CTLA4 immunotherapy.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P932